At a glance
ClinicalIndex Comparison RecordN/ACompleted· 157 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Defective Atypical PKC Activation in Diabetes and Metabolic Syndrome
In Brief
An observational study for Diabetes Mellitus, Type 2. Completed, enrolled 157 participants across 1 site.
Detailed Summary
The investigators are examining the activation of insulin signaling factors in skeletal muscles of human diabetics. The investigators are characterizing the defects in signaling, and are examining the effects of anti-diabetic agents and exercise on signaling to glucose transport biochemical machinery and whole body glucose disposal.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2000
First PostedJun 2008
Primary CompletionSep 2012
TodayJul 2026
First PostedJun 5, 2008
Enrollment StartMay 1, 2000
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 12.3 yearsPosted 18.1 years ago